SLN
Silence Therapeutics PLC
NASDAQ: SLN · HEALTHCARE · BIOTECHNOLOGY
$7.31
+2.81% today
Updated 2026-04-30
Market cap
$363.70M
P/E ratio
—
P/S ratio
650.63x
EPS (TTM)
$-1.89
Dividend yield
—
52W range
$4 – $8
Volume
0.4M
Silence Therapeutics PLC (SLN) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
3 of 8
Last 8 quarters
Avg EPS surprise
-53.4%
Last 4 quarters
Revenue YoY growth
-99.9%
Most recent quarter
EPS YoY growth
-258.8%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-3.1%
Last 2 reports
Positive reaction rate
50%
1 of 2 quarters
Largest single-day move
-7.7%
2026-03-18
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-03-18 | $-0.27 | -33.9% | $6.91 | $6.38 | -7.7% |
| 2025-11-13 | $-0.15 | +28.6% | $6.73 | $6.83 | +1.5% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $-0.20 | $-0.27 | -33.9% | $34000.00 | -99.9% |
| 2025-09-30 | $-0.21 | $-0.15 | +28.6% | $159000.00 | -86.1% |
| 2025-06-30 | $-0.21 | $-0.55 | -161.9% | $224000.00 | -62.5% |
| 2025-03-31 | $-0.41 | $-0.60 | -46.3% | $142000.00 | -99.1% |
| 2024-12-31 | $-0.25 | $0.17 | +169.3% | $24.33M | +1059.0% |
| 2024-09-30 | $-0.14 | $-0.73 | -421.4% | $1.14M | -59.2% |
| 2024-06-30 | $-0.11 | $-0.43 | -273.5% | $598000.00 | -93.4% |
| 2024-03-31 | $-0.11 | $-0.05 | +52.7% | $15.70M | +38.0% |
| 2023-12-31 | $-0.08 | $-0.45 | -480.1% | $2.10M | — |
| 2023-09-30 | $-0.17 | $-0.07 | +58.8% | $2.80M | — |
| 2023-06-30 | $-0.17 | $-0.12 | +29.2% | $9.10M | — |
| 2023-03-31 | $-0.15 | $-0.12 | +21.3% | $11.37M | — |
Frequently asked questions
Has Silence Therapeutics PLC beaten earnings estimates?
Silence Therapeutics PLC has beaten Wall Street EPS estimates in 3 of its last 8 quarterly reports, with an average EPS surprise of -53.4% over the last 4 quarters.
How does SLN stock react to earnings?
SLN stock has moved an average of -3.1% in the trading day following earnings over its last 2 reports, with positive reactions in 50% of those quarters.
What is Silence Therapeutics PLC's revenue growth rate?
Silence Therapeutics PLC reported year-over-year revenue growth of -99.9% in its most recent quarter, with EPS growing -258.8% year-over-year.